类型2:一种针对抗瘤免疫治疗的候选药物.
Luxia Xu1, Feiyan Pan1, Zhigang Guo1
1Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China.
Journal of immunology (Baltimore, Md. : 1950)
|February 20, 2024
概括
TNF-α诱导的8-样蛋白2 (TIPE2) 是免疫反应和炎症的关键调节者. 需要进一步的研究才能充分理解TIPE2 .
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 由TNF-α诱导的8-样蛋白2 (TIPE2) 是一种新的天生的和适应性免疫的负调节剂.
- TIPE2维持免疫平衡,并参与炎症和瘤发育.
- 它的表达跨越各种免疫和非免疫组织.
研究的目的:
- 审查TIPE蛋白质的结构特征,表达模式和功能作用.
- 强调TIPE2在免疫调节中的作用和机制.
- 探索TIPE2在各种疾病背景中的参与.
主要方法:
- 文献综述侧重于TIPE蛋白研究.
- 分析详细研究TIPE2表达和功能的研究.
- 检查证据,将TIPE2与免疫调节和疾病联系起来.
主要成果:
- TIPE2表现出广泛的组织表达,影响免疫和非免疫细胞.
- TIPE2显著影响炎症反应和瘤进展.
- 目前对TIPE2复杂功能的理解仍然有限.
结论:
- TIPE2是免疫反应的关键调节者,对健康和疾病有影响.
- 目前对TIPE2复杂作用的理解是有限的.
- 需要进一步的研究,以阐明TIPE2在各种疾病环境中的功能.
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cytotoxic T Cells-mediated Immune Response
910
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
910


